VentriPoint Diagnostics (TSXV:VPT) Accounts Payable & Accrued Expense : C$1.25 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics Accounts Payable & Accrued Expense?

VentriPoint Diagnostics's quarterly accounts payable & accrued expense increased from Jun. 2023 (C$0.98 Mil) to Sep. 2023 (C$1.10 Mil) and increased from Sep. 2023 (C$1.10 Mil) to Dec. 2023 (C$1.25 Mil).

VentriPoint Diagnostics's annual accounts payable & accrued expense declined from Dec. 2021 (C$1.05 Mil) to Dec. 2022 (C$0.96 Mil) but then increased from Dec. 2022 (C$0.96 Mil) to Dec. 2023 (C$1.25 Mil).

VentriPoint Diagnostics Accounts Payable & Accrued Expense Historical Data

The historical data trend for VentriPoint Diagnostics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Accounts Payable & Accrued Expense Chart

VentriPoint Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.65

1.78

1.05

0.96

1.25

VentriPoint Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.96	0.99	0.98	1.10	1.25

VentriPoint Diagnostics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

VentriPoint Diagnostics (TSXV:VPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

VPTDF:USA 5V7:Germany

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

Executives

Robert Hodgkinson

Director

VentriPoint Diagnostics (TSXV:VPT) Headlines

No Headlines